About Strata Oncology
Strata Oncology is a company based in Ann Arbor (United States) founded in 2015 by Scott Tomlins and Dan Rhodes.. Strata Oncology has raised $139.15 million across 5 funding rounds from investors including Monashee Investment Management, eLab Ventures and Wellington. The company has 125 employees as of December 31, 2022. Strata Oncology offers products and services including Antibody-drug Conjugate Treatment Response Scores and Immunotherapy Response Score. Strata Oncology operates in a competitive market with competitors including ArcherDX, Personalis, Variantyx, ImaginAb and OncoDNA, among others.
- Headquarter Ann Arbor, United States
- Employees 125 as on 31 Dec, 2022
- Founders Scott Tomlins, Dan Rhodes
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$139.15 M (USD)
in 5 rounds
-
Latest Funding Round
$6.15 M (USD), Series C
Nov 08, 2024
-
Investors
Monashee Investment Management
& 9 more
-
Employee Count
125
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Strata Oncology
Strata Oncology offers a comprehensive portfolio of products and services, including Antibody-drug Conjugate Treatment Response Scores and Immunotherapy Response Score. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predictive method for assessing ADC benefits in cancer therapy.
Algorithm evaluating PD-L1 and tumor factors for immunotherapy efficacy.
Unlock access to complete
Funding Insights of Strata Oncology
Strata Oncology has successfully raised a total of $139.15M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $6.15 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series C — $6.1M
-
First Round
First Round
(04 Mar 2016)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series C - Strata Oncology | Valuation |
investors |
|
| Jul, 2021 | Amount | Series C - Strata Oncology | Valuation | Wellington | |
| Nov, 2020 | Amount | Series B - Strata Oncology | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Strata Oncology
Strata Oncology has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Monashee Investment Management, eLab Ventures and Wellington. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is focused on healthcare by Pfizer's investment arm.
|
Founded Year | Domain | Location | |
|
Corporate-backed venture capital is focused on the life science sector.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Strata Oncology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Strata Oncology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Strata Oncology Comparisons
Competitors of Strata Oncology
Strata Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Personalis, Variantyx, ImaginAb and OncoDNA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| domain | founded_year | HQ Location |
Provider of test panels for personalized cancer therapies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Strata Oncology
Frequently Asked Questions about Strata Oncology
When was Strata Oncology founded?
Strata Oncology was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Strata Oncology located?
Strata Oncology is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Who is the current CEO of Strata Oncology?
Dan Rhodes is the current CEO of Strata Oncology. They have also founded this company.
Is Strata Oncology a funded company?
Strata Oncology is a funded company, having raised a total of $139.15M across 5 funding rounds to date. The company's 1st funding round was a Series B of $5M, raised on Mar 04, 2016.
How many employees does Strata Oncology have?
As of Dec 31, 2022, the latest employee count at Strata Oncology is 125.
What does Strata Oncology do?
Strata Oncology was founded in 2015 in Ann Arbor, United States, within the precision oncology sector. Genetic sequencing services are offered to late-stage cancer patients. Partnerships are established with biopharma companies and healthcare institutions to identify suitable ongoing clinical trials. This approach is used to facilitate patient matching and increase enrollment in precision oncology studies. Operations focus on supporting trial access through data-driven insights.
Who are the top competitors of Strata Oncology?
Strata Oncology's top competitors include Personalis, ImaginAb and OncoDNA.
What products or services does Strata Oncology offer?
Strata Oncology offers Antibody-drug Conjugate Treatment Response Scores and Immunotherapy Response Score.
Who are Strata Oncology's investors?
Strata Oncology has 10 investors. Key investors include Monashee Investment Management, eLab Ventures, Wellington, HIGHSIDE Global, and Pfizer Venture Investments.